Variant report
Variant | esv3393660 |
---|---|
Chromosome Location | chr3:84108311-84132206 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:234747206..234748910-chr3:84128270..84130556,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CADM2-3 | chr3:84122482-84122569 | l_2403_chr3:84085490-84141354_heart |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185415749 | chr3:84115826-84115827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369357197 | chr3:84115848-84115849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546114050 | chr3:84115883-84115884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550347570 | chr3:84115898-84115899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190222849 | chr3:84115973-84115974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536134260 | chr3:84116001-84116002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34801360 | chr3:84116020-84116021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6548933 | chr3:84116027-84116028 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs562707196 | chr3:84116039-84116040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371987217 | chr3:84116049-84116050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572429006 | chr3:84116055-84116056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368744539 | chr3:84116058-84116059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558168642 | chr3:84116061-84116062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144257935 | chr3:84116099-84116100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116799807 | chr3:84116108-84116109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374334929 | chr3:84116137-84116138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182886332 | chr3:84116178-84116179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187519342 | chr3:84116189-84116190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559118455 | chr3:84116230-84116231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542066836 | chr3:84116233-84116234 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191863029 | chr3:84116244-84116245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183718468 | chr3:84116254-84116255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs80062599 | chr3:84116320-84116321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79874755 | chr3:84116343-84116344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2091488 | chr3:84116366-84116367 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs564520827 | chr3:84116417-84116418 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112028661 | chr3:84116437-84116438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141312791 | chr3:84116469-84116470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2091489 | chr3:84116522-84116523 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs568557971 | chr3:84116574-84116575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535647915 | chr3:84116577-84116578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547591906 | chr3:84116599-84116600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545753244 | chr3:84116628-84116629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530105016 | chr3:84116645-84116646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114472816 | chr3:84116657-84116658 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1528053 | chr3:84116673-84116674 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs373130663 | chr3:84116702-84116703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558105644 | chr3:84116766-84116767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189110497 | chr3:84116770-84116771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs77400054 | chr3:84116796-84116797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs80070214 | chr3:84116804-84116805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192247921 | chr3:84116814-84116815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542005189 | chr3:84116837-84116838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182957279 | chr3:84116844-84116845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572368798 | chr3:84116872-84116873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546147658 | chr3:84116900-84116901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564491856 | chr3:84116924-84116925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114315837 | chr3:84116941-84116942 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs118079425 | chr3:84116989-84116990 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533453645 | chr3:84117104-84117105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:84115800-84116600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr3:84116000-84116200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr3:84116200-84116600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr3:84116200-84116800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr3:84116200-84117000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr3:84116200-84124800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr3:84116400-84116800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr3:84116800-84122000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr3:84119800-84120000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr3:84119800-84120000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr3:84121200-84121800 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
12 | chr3:84121400-84122200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr3:84121600-84122600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
14 | chr3:84121800-84122400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr3:84122000-84123400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr3:84122200-84122400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
17 | chr3:84122400-84122800 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
18 | chr3:84122400-84123400 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
19 | chr3:84122800-84124200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr3:84122800-84125200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr3:84123000-84123200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
22 | chr3:84124000-84124200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |